PZZ Prospect Medical Hldgs (MM)

Goldfarb Branham LLP is pursuing shareholder claims against the board of Prospect Medical Holdings (NASDAQ: PZZ) in connection with the proposed buyout. The acquisition will cash out investors for $8.50 per share. If you are a Prospect shareholder, you are encouraged to contact the firm at 877-583-2855 or hlindley@goldfarbbranham.com to learn about your rights.

“Company insiders own nearly 50% of Prospect’s shares and have entered into an agreement to vote all their shares in favor of the transaction and agreed to exchange almost 6.2 million of their shares for equity interests in the acquiring company,” said securities lawyer Hamilton Lindley. “Additionally, because at least one analyst has set a price target of $16.20 per share, this deal could be unfair to shareholders. Our proposed class action lawsuit seeks better value for the company as well as more information about this transaction disclosed to shareholders.”

Goldfarb Branham LLP lawyers have significant experience representing shareholders in unfair buyouts nationwide. The national securities firm provides nimble, creative and effective counsel at all stages of litigation. If you have information or concerns about this transaction, contact attorney Hamilton Lindley at the contact numbers listed below.

Prospect Medical Hldgs (MM) (NASDAQ:PZZ)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025

Prospect Medical Hldgs (MM) (NASDAQ:PZZ)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025